tert-Butyl (5S)-5-(((tert-butyldiphenylsilyl)oxy)methyl)-2-ethynyl-2-hydroxypyrrolidine-1-carboxylate

Catalog No. :
ACVAMH351
CAS No. :
833473-90-8
Molecular Formula :
C28H37NO4Si
Molecular Weight :
479.69

IUPAC Name:tert-butyl (5S)-5-(((tert-butyldiphenylsilyl)oxy)methyl)-2-ethynyl-2-hydroxypyrrolidine-1-carboxylate

tert-Butyl (5S)-5-(((tert-butyldiphenylsilyl)oxy)methyl)-2-ethynyl-2-hydroxypyrrolidine-1-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (5S)-5-(((tert-butyldiphenylsilyl)oxy)methyl)-2-ethynyl-2-hydroxypyrrolidine-1-carboxylate
IUPAC Nametert-butyl (5S)-5-(((tert-butyldiphenylsilyl)oxy)methyl)-2-ethynyl-2-hydroxypyrrolidine-1-carboxylate
Molecular FormulaC28H37NO4Si
Molecular Weight479.69
SMILESO=C(N1C(O)(C#C)CC[C@H]1CO[Si](C2=CC=CC=C2)(C(C)(C)C)C3=CC=CC=C3)OC(C)(C)C
InChI KeyTXPIJJSLSVYXIA-XYXHBKGXSA-N
Synonym1-Pyrrolidinecarboxylic acid, 5-[[[(1,1-dimethylethyl)diphenylsilyl]oxy]methyl]-2-ethynyl-2-hydroxy-, 1,1-dimethylethyl ester, (5S)-;tert-Butyl (5S)-5-(((tert-butyldiphenylsilyl)oxy)methyl)-2-ethynyl-2-hydroxypyrrolidine-1-carboxylate
CAS No.833473-90-8

Synthetic Route by SureRoute

1. ACVAMH351 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMJIF189 route compound structure diagram
    ACMJIF189138871-56-4 In Stock
  4. Then
  5. ACVAMH351 route product structure diagram
    ACVAMH351833473-90-8
Inquiry

2. ACVAMH351 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACMJIF189 route compound structure diagram
    ACMJIF189138871-56-4 In Stock
  4. Then
  5. ACVAMH351 route product structure diagram
    ACVAMH351833473-90-8
Inquiry

Comments (0)